Nectin obtains funds for Phase I trial of immunotherapy for solid tumours
Nectin Therapeutics has announced an investment of $5.4m from Cancer Focus Fund for a Phase I trial of NTX1088 to treat solid tumour patients.
Stay updated with breaking news from Focus Fund. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Nectin Therapeutics has announced an investment of $5.4m from Cancer Focus Fund for a Phase I trial of NTX1088 to treat solid tumour patients.
In this article, we will share the insights on 10 large-cap stocks hedge funds are talking about.
PBS Wisconsin will celebrate Martin Luther King Jr. Day with a special presentation of its series Why Race Matters, at 8:00 p.m. Monday, Jan. 17, on PBS Wisconsin. Why Race Matters is a digital series elevating issues of importance affecting Wisconsin’s Black communities. Host and producer Angela Fitzgerald connects in conversation with everyday people whose work and commitments center on race, identity and achieving racial equity in the state. The series explores topics simultaneously historic and urgent, while offering hope, guidance and resources to thrive. The discussions featured inÂ...
Ariel Investments, an investment management firm, published its "Ariel Focus Fund" third-quarter 2021 investor letter – a copy of which can be downloaded here.
Ariel Investments, an investment management firm, published its "Ariel Focus Fund" third-quarter 2021 investor letter – a copy of which can be downloaded here.